Phytochemical Profiling, Cytotoxicity and Anti-inflammatory Potential of Salvia hispanica L. Seeds

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Mohamed H.R.; El-Wakil E.A.; Hamed M.M.; El-Shahid Z.A.E.-K.

Journal: Egyptian Journal of Chemistry

Publisher: National Information and Documentation Centre

Publication Date: 14 October 2024

Volume / Issue: Volume 67 / Issue 12

Pages: 409–422

ISSN: 4492285

DOI: 10.21608/ejchem.2024.303803.10000

Scopus: View on Scopus

Document Type: Article


Authors and Affiliations

Mohamed H.R., Department of Medicinal Chemistry, Theodor Bilharz Research Institute, Korniash El-Nile, Warrak El-Hadar, Giza, 12411, Egypt; El-Wakil E.A., Department of Medicinal Chemistry, Theodor Bilharz Research Institute, Korniash El-Nile, Warrak El-Hadar, Giza, 12411, Egypt; Hamed M.M., Department of Medicinal Chemistry, Theodor Bilharz Research Institute, Korniash El-Nile, Warrak El-Hadar, Giza, 12411, Egypt; El-Shahid Z.A.E.-K., Department of Chemistry of Natural and Microbial Products, National Research Centre, Dokki, Giza, 12622, Egypt


Abstract

Seeds of Salvia hispanica L. (chia seeds) have recently gained increasing attention as a functional food with numerous therapeutic benefits. The ethyl acetate and the methanol extracts of chia seeds were evaluated for their anti-inflammatory potential by measuring Nitric oxide production in LPS-stimulated RAW 264.7 cells and cytotoxic activity against HepG2, Paca II, HCT116, and HT29 cancer cell lines using MTT assay. The phytochemical composition was analyzed via GC-MS and UPLC-MS. Nineteen compounds were tentatively identified in the methanol extract via LC-MS and 10 compounds from the ethyl acetate extract by GC/MS. The ethyl acetate extract showed a remarkable cytotoxic effect against HepG2 and Paca-II with IC50 of 11 µg/mL and 87.7 µg/mL, respectively. The pre-treatment with both extracts significantly suppressed the NO production in LPS-stimulated RAW 264.7 cells. The results indicated that; S. hispanica L. seeds could be used as a potent anti-inflammatory and anticancer herbal medicine especially against hepatocellular carcinoma. ©2024 National Information and Documentation Center (NIDOC)


Keywords

anti-inflammatory; anticancer; GC/MS; Salvia hispanica L; UPLC-ESI-MS


Citation Information

Scopus Citations: 3


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

Transcriptome analysis for Schistosoma vector snail’s Oncomelania hupensis exposed to silver nanoparticles

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer